Adaptation and validation of the Genetic Counseling Outcome Scale for autism spectrum disorders and related conditions
Affiliations
- PMID: 32893416
- DOI: 10.1002/jgc4.1323
Abstract
The genetics care pathway experienced by families affected by autism spectrum disorder (ASD) around the time of diagnosis is currently uncharacterized and potentially variable across contexts. The lack of consensus on outcome measures to capture the impact of genetic services for these families shows a gap in understanding and optimizing this genetics care pathway. The Genetic Counseling Outcome Scale (GCOS-24) is a validated outcome measure of clinical genetics services. The current study aims to adapt and validate the GCOS-24 as an outcome measure in the context routine genetic testing in ASD and related conditions. Families seen for their child's developmental evaluation for ASD and related conditions were invited to participate in a genomics cohort between 2016 and 2018. Families (n = 111) completed the mGCOS-24 (modified GCOS-24), adapted from the original GCOS-24 by clinicians working in the target population's routine care pathway. The mGCOS-24 has acceptable internal consistency (Cronbach's α = 0.84) and high test-retest reliability (ICC = 0.88). It also inversely correlates with stress as measured by Perceived Stress Scale (PSS-10) and distress, as measured by the Distress Thermometer, rs ≥ 0.39, ps < 0.001. The mGCOS-24 had adequate readability, as supported by cognitive interviews completed by a sub-sample of five mothers of a child with ASD. Together, our findings show that the mGCOS-24 has good validity for the target population. Preliminary characterization of the genetics care pathway in this population revealed remarkable variability in pre-test counseling and limited post-test counseling. The use of the mGCOS-24 as an outcome measure is useful in filling some of these gaps by offering a way to assess, and in the future, optimize the genetics care pathway for families affected by autism and related neurodevelopmental conditions.
Keywords: autism spectrum disorder; empowerment; genetic testing; patient-reported outcome measures.
© 2020 The Authors. Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.
Similar articles
- Adaptation and preliminary validation of the genetic counseling outcome scale (GCOS-24) in a Brazilian genetic counseling setting.Eur J Med Genet. 2020 Jul 31;63(11):104018. doi: 10.1016/j.ejmg.2020.104018. Online ahead of print.PMID: 32739285
- Translation and Cross-Cultural Adaptation with Preliminary Validation of GCOS-24 for Use in Spain.J Genet Couns. 2018 Jun;27(3):732-743. doi: 10.1007/s10897-017-0154-z. Epub 2017 Sep 25.PMID: 28944441
- Translation and Adaptation of the Genetic Counselling Outcome Scale (GCOS-24) for Use in Denmark.J Genet Couns. 2017 Oct;26(5):1080-1089. doi: 10.1007/s10897-017-0086-7. Epub 2017 Mar 6.PMID: 28265802
- The genetics of autism.Pediatrics. 2004 May;113(5):e472-86. doi: 10.1542/peds.113.5.e472.PMID: 15121991 Review.
- Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD).Cochrane Database Syst Rev. 2014 Mar 21;2014(3):CD008785. doi: 10.1002/14651858.CD008785.pub2.PMID: 24652601 Free PMC article. Review.
No hay comentarios:
Publicar un comentario